Constellation Brands (STZ)
$206.64 2.82 (1.38%)
14:30 EST STZ Stock Quote Delayed 15 Minutes
Previous Close $203.82
Market Cap 34.69B
PE Ratio 15.49
Volume (Avg. Vol.) 469,704
Day's Range 203.98 - 206.75
52-Week Range 163.52 - 214.48
Dividend & Yield 2.74 (1.33%)
STZ Stock Predictions, Articles, and Constellation Brands News
- From InvestorPlace
- From the Web
The Constellation Brands earnings report for the company's fiscal fourth quarter of the year has STZ stock up on Thursday.
They're only threats for the time being, but should they become a reality, look for these names to suffer from a border closure.
Full marijuana legalization is proving a heavy lift in state legislatures, meaning Constellation shareholders will have to wait to cash in on their $4.4 billion Canopy Growth buy.
Investors have heard a ton about cannabis stocks and their ridiculous valuations. But Wall Street analysts say these pot stocks still have a lot of upside ahead.
The ETFMG Alternative Harvest (MJ) ETF enables investors to take advantage of long-term trends in marijuana stocks.
Aurora Cannabis (ACB) stock continues to rise, and investors may understandably be scared to jump in now. Here's what you should do ...
Bulls can keep their portfolios from getting smoked with cannabis leaders CGC stock and SMG stock, which are ripe for breakouts.
Data refutes the idea that cannabis sales will steal share from alcohol sales, and that means STZ stock is a buy on this recent dip.
The big rally from Cronos Group stock has stalled, but too many investors are certain it's just a breather before another leg higher.
Constellation Brands stock hit a 23-month low after reporting disappointing earnings. But STZ stock has rallied since and should keep moving higher.
Aurora Cannabis stock has risen nicely in 2019. But longer-term, ACB stock is likely to be either a big winner or a big loser.
Take advantage of the market uncertainty, political bickering and economic unrest with these smart stocks to invest in.
CRON is a hyper-momentum stock and there's no perfect time to buy it. Valuation aside, cannabis investing is young and the potential is great.
If volatility reappears, consumer stocks are a great thing to have in your portfolio. Here are 5 consumer staples stocks from Wells Fargo.
Thankfully, the start to 2019 has been much better than 2018's end. Here are seven stocks to buy that are due for a comeback this year.
These five beaten-down value stocks could see a relief rally amid a strong fourth-quarter earnings season.
NBEV stock hasn't raced higher like pot stocks have following recent cannabis-based news, but New Age Beverages is still well-positioned.
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader